"The US Food and Drug Administration (FDA) has approved Akorn Inc's phenylephrine hydrochloride ophthalmic solution (2.5% and 10%), the company has announced.
The alpha-1 adrenergic receptor agonist is commonly used by optometrists, ophtha"...
Zirgan Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Zirgan (ganciclovir ophthalmic gel) is used to treat herpes infection of the eye. It is an anti-viral drug. Common side effects include temporary blurred vision after application of this medication and mild eye irritation/redness.
The recommended dosing regimen for Zirgan gel is 1 drop in the affected eye 5 times per day (approximately every 3 hours while awake) until the corneal ulcer heals, and then 1 drop 3 times per day for 7 days. Zirgan may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Zirgan should be used only when prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
Our Zirgan (ganciclovir ophthalmic gel) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information in Detail?
Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.
Zirgan in Detail - Patient Information: Side Effects
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have a serious side effect such as:
- eye pain, swelling, redness, or watering;
- severe burning or itching of your eyes;
- vision changes, increased sensitivity to light;
- tunnel vision, problems with peripheral (side) vision;
- seeing flashes of light, halos around lights, or "floaters" in your vision;
- white patches on your eyes;
- cloudiness in the pupils or iris of your eyes;
- bleeding, oozing, or crusting of your eyes; or
- sudden vision loss.
Less serious side effects may include:
- blurred vision (may last up to 4 weeks after Vitrasert implant surgery);
- mild eye irritation; or
- increased tearing.
Read the entire detailed patient monograph for Zirgan (Ganciclovir Ophthalmic Gel) »
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Zirgan Overview - Patient Information: Side Effects
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
A very serious allergic reaction to this drug is rare. However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Zirgan (Ganciclovir Ophthalmic Gel)»
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Zirgan FDA Prescribing Information: Side Effects
Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).
Read the entire FDA prescribing information for Zirgan (Ganciclovir Ophthalmic Gel) »
Additional Zirgan Information
Zirgan - User Reviews
Zirgan User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Get breaking medical news.